Primary Hepatic Neuroendocrine Tumor with Hepatocellular Carcinoma: A Rare Case Report
Asian Journal of Case Reports in Surgery,
Aim: Hepatocellular carcinoma is the most common primary liver malignancy followed by intrahepatic cholangiocarcinoma. The diagnosis of primary hepatic neuroendocrine tumor, a rare liver lesion, generally occurs during histological examination.
Case Report: A 48 year old male patient presented with a lesion in the segment 5/6 of liver clinically and imaging features suggestive of Hepatocellular carcinoma. He underwent resection of the lesion. Final histopathological analysis of the lesion showed combined Hepatocellular carcinoma and neuroendocrine tumor. DOTANAC scan was done postoperatively which confirmed primary hepatic neuroendocrine tumor by ruling out primary neuroendocrine tumor elsewhere. He is currently on adjuvant chemotherapy.
Discussion and Conclusion: Primary hepatic neuroendocrine tumor is a rare malignancy. It is mandatory to search for primary neuroendocrine tumors in rest of the gastrointestinal system before making the diagnosis. Combined Hepatocellular carcinoma and primary hepatic neuroendocrine tumor is a rare tumor which needs multidisciplinary team discussion to formulate treatment plan.
- Hepatocellular carcinoma
- hepatic neuroendocrine tumor
- Ki 67
- Hep Par
- CD 56
How to Cite
Maggard MA, O’Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240(1):117–22.
Kellock T, Tuong B, Harris AC, Yoshida E. Diagnostic Imaging of Primary Hepatic Neuroendocrine Tumors: A Case and Discussion of the Literature. Case Rep Radiol. 2014;2014:e156491.
Dasgupta P, Henshaw C, Youlden DR, Clark PJ, Aitken JF, Baade PD. Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis. Front Oncol. 2020;10:171.
Petrick JL, McGlynn KA. The changing epidemiology of primary liver cancer. Curr Epidemiol Rep. 2019;6(2):104–11.
Gaillard F. Hepatocellular carcinoma | Radiology Reference Article | Radiopaedia.org [Internet]. Radiopaedia. [cited 2022 Nov 28].
Guidelines Detail [Internet]. NCCN. [cited 2022 Aug 19].
Vogel A, Martinelli E, Vogel A, Cervantes A, Chau I, Daniele B, et al. Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines. Ann Oncol. 2021;32(6):801–5.
Choi GH, Ann SY, Lee SI, Kim SB, Song IH. Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature. World J Gastroenterol. 2016;22(41):9229–34.
Lan J, Guo D, Qin X, Chen B, Liu Q. Mixed Neuroendocrine Carcinoma and Hepatocellular Carcinoma: A Case Report and Literature Review. Front Surg [Internet]. 2021 [cited 2022 Nov 28];8.
Barsky SH, Linnoila I, Triche TJ, Costa J. Hepatocellular carcinoma with carcinoid features. Hum Pathol. 1984;15(9):892–4.
Artopoulos JG, Destuni C. Primary mixed hepatocellular carcinoma with carcinoid characteristics. A case report. Hepatogastroenterology. 1994; 41(5):442–4.
Vora IM, Amarapurkar AD, Rege JD, Mathur SK. Neuroendocrine differentiation in hepatocellular carcinoma. Indian J Gastroenterol Off J Indian Soc Gastroenterol. 2000;19(1):37–8.
Aboelenen A, El-Hawary AK, Megahed N, Zalata KR, El-Salk EM, Fattah MA, et al. Right hepatectomy for combined primary neuroendocrine and hepatocellular carcinoma. A case report. Int J Surg Case Rep. 2014;5(1):26–9.
Abstract View: 30 times
PDF Download: 11 times